Pregnancy & Medications

Anti-Epileptic Drugs in Reproductive Age Women: Valproic Acid and Topiramate Commonly Used

There have long been concerns regarding the safety of the anticonvulsant valproic acid (Depakote) during pregnancy.  Back in 2009, the American Academy of Neurology and American Epilepsy Society recommended against the use of valproic acid [...]

By |2025-06-26T09:07:43-04:00April 9th, 2019|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Anti-Epileptic Drugs in Reproductive Age Women: Valproic Acid and Topiramate Commonly Used

Prenatal Exposure to Valproic Acid: ADHD and Other Deficits in Cognitive Functioning

Previous studies have shown that children exposed to antiepileptic drugs (AEDs) during pregnancy may be at increased risk for neurodevelopmental disorders.  In a recent population-based cohort study from Denmark, researchers examined the prevalence of [...]

By |2025-06-26T09:07:45-04:00January 11th, 2019|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Prenatal Exposure to Valproic Acid: ADHD and Other Deficits in Cognitive Functioning

Treatment of Panic Disorder with Antidepressants Associated with Better Outcomes

While we have focused a great deal on the emergence of mood disorders during pregnancy and the postpartum period, there is a growing body of literature that indicates that anxiety symptoms are prevalent during this [...]

By |2018-11-21T14:37:56-04:00November 21st, 2018|Pregnancy & Medications|Comments Off on Treatment of Panic Disorder with Antidepressants Associated with Better Outcomes

No Increased Risk of Autism in Children Prenatally Exposed to Commonly Used Antidepressants

Concerns regarding a link between antidepressant use during pregnancy and autism emerged when two epidemiologic studies demonstrated an association between prenatal exposure to selective serotonin reuptake inhibitor antidepressants (SSRIs) with an increased risk of autism [...]

By |2018-11-14T15:53:24-04:00November 14th, 2018|Pregnancy & Medications|Comments Off on No Increased Risk of Autism in Children Prenatally Exposed to Commonly Used Antidepressants

New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

The newer “atypical” or second-generation antipsychotic agents are now used  to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders.  The National Pregnancy Registry for Atypical Antipsychotics [...]

By |2018-10-18T10:27:45-04:00August 24th, 2018|Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester.  Anxiety during pregnancy is not necessarily a benign event.  Various studies indicate [...]

By |2018-08-09T11:56:54-04:00August 2nd, 2018|Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Valproic Acid: Highlighting Risk and Modifying Prescribing Patterns in Reproductive Age Women

For clinicians who have not yet discovered the incredibly thoughtful and clinically practical monthly articles from Chittaranjan Andrade in the Journal of Clinical Psychiatry, it’s time to take a look.  (Not only are these articles [...]

By |2019-04-05T08:04:27-04:00July 3rd, 2018|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Valproic Acid: Highlighting Risk and Modifying Prescribing Patterns in Reproductive Age Women
Go to Top